Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple myeloma: signaling pathways and targeted therapy
Qizhong Lu, Donghui Yang, Hexian Li, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

Insights into IL-6/JAK/STAT3 Signaling in the Tumor Microenvironment: Implications for Cancer Therapy
Win Lwin Thuya, Yang Cao, Paul Chi-Lui Ho, et al.
Cytokine & Growth Factor Reviews (2025)
Closed Access
Predicting the Progression from Asymptomatic to Symptomatic Multiple Myeloma and Stage Classification Using Gene Expression Data
Nestoras Karathanasis, George M. Spyrou
Cancers (2025) Vol. 17, Iss. 2, pp. 332-332
Open Access
Detection of early relapse in multiple myeloma patients
Tereza Růžičková, Monika Vlachová, Lukáš Pečínka, et al.
Cell Division (2025) Vol. 20, Iss. 1
Open Access
Targeting ABCD1-ACOX1-MET/IGF1R axis suppresses multiple myeloma
Zhannan Han, Zhibo Yan, Zhehan Ma, et al.
Leukemia (2025)
Closed Access
Insights into the Molecular Mechanisms and Nanoparticle-Based Therapies for Gastric Cancer: A review
Smarika Chauhan, Eswar Marcharla, Sneha Hariharan, et al.
Results in Engineering (2025), pp. 104238-104238
Open Access
MiRNA-21 promotes the migration and proliferation of prostate cancer cells via activating the JAK/STAT pathway
Xin Han, Changjun Lv
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
PHLPP and LAMP2 predict favorable treatment response and survival in multiple myeloma patients who receive induction treatment with bortezomib
Qingkun Han, Wei Han, Cuiping Li, et al.
Irish Journal of Medical Science (1971 -) (2025)
Closed Access
Pathways regulating intestinal stem cells and potential therapeutic targets for radiation enteropathy
Si-Min Chen, Bing-Jie Guo, A Lei Feng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 3
Bispecific antibodies for the treatment of hematologic malignancies: The magic is T-cell redirection
Geoffrey Shouse
Blood Reviews (2024), pp. 101251-101251
Closed Access | Times Cited: 1
Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future Directions
Caterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal Of Haematology (2024)
Closed Access | Times Cited: 1
Antibody avidity meets multiple myeloma
Sigrid R. Ruuls, Paul W.H.I. Parren
Nature Cancer (2024)
Closed Access
Current Strategies and Future Directions in Multiple Myeloma: Disease Overview and Pathophysiology, Conventional Treatments and Emerging Therapies, Challenges and Innovations in Management
Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, et al.
European Journal of Medical and Health Research (2024) Vol. 2, Iss. 5, pp. 10-26
Closed Access
Machine Learning Models for Predicting Multiple Myeloma Staging and MGUS Progression Using Gene Expression Data
Nestoras Karathanasis, George M. Spyrou
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top